Pharmaceutical Policy Sharing Forum

Agendas
14:00 - 17:30
  • 医药政策分享论坛
  • Pharmaceutical Policy Sharing Forum
14:00 - 14:05
  • 致辞
  • Welcome Remarks
14:05 - 15:45
  • 第一阶段：医药政策主题报告
  • Phase Ⅰ：Pharmaceutical Policy Theme Report
    • Moderator
  • 胡欣 ， 中国药促会医药政策专业委员会主任委员，北京医院药学部主任药师、首席专家
  • HU Xin , Chairman of PhIRDA Medicinal Policy Specialty Committee, Chief Pharmacist & Chief Expert of the Department of Pharmacy of Beijing Hospital
14:05 - 14:30
  • 主题报告1
  • Keynote Speech 1
  • 对当前医药经济运行趋势的几点思考
  • Several Thoughts on the Current Trend of the Development of Pharmaceutical Economy
  • 林建宁 南方医药经济研究所原党委书记
  • LIN Jianning , Former Party Secretary of National Medical Products Administration Institute of Medical Economics
14:30 - 14:55
  • 主题报告2
  • Keynote Speech 2
  • 香港药械监管的改革及展望
  • Reform and Prospects of Drug and Medical Device Regulation in Hong Kong
  • 陈诗涛 香港特別行政区政府卫生署总药剂师
  • CHAN Sze Tao , Chief Pharmacist of Department of Health of Hong Kong Special Administrative Region Government
14:55 - 15:20
  • 主题报告3
  • Keynote Speech 3
  • “港澳药械通”政策最新进展介绍
  • Introduction to the Latest Progress of the "Hong Kong and Macao Medicine and Equipment Connect" Policy
  • 罗玉冰 广东省药品监督管理局行政许可处处长
  • LUO Yubing , Director of the Administrative Licensing Division of the Guangdong Provincial Drug Administration
15:20 - 15:45
  • 主题报告4
  • Keynote Speech 4
  • 商业健康保险支持医药创新实践与挑战
  • Commercial Health Insurance Supporting Medical Innovation Practices and Challenges
  • 韩世明 波士顿咨询公司董事总经理兼全球合伙人
  • Samuel Han , Managing Director  & Global Partner of Boston Consulting Group
15:45 - 17:30
  • 第二阶段：产业趋势主题讨论
  • Phase II：Industry Trends Discussion
15:45 - 16:40
  • 主题讨论1
  • Panel Discussion 1
  • 商保助推医药创新
  • Commercial Health Insurance Promoting Pharmaceutical Innovation
    • Moderator
  • 刘军帅 ， 中国药促会医药政策专业委员会副主任委员，国家罕见病诊疗与保障专家委员会委员
  • LIU Junshuai , Vice-Chairman of Medicinal Policy Specialty Committee of PhIRDA, Member of Specialty Committee on Diagnosis of Treatment and Protection of Rare Diseases
    • Panelists
  • 金春林 ， 上海市卫生和健康发展研究中心主任
  • JIN Chunlin , Director of Shanghai Health Development Research Center
  • 韩世明 ， 波士顿咨询公司董事总经理兼全球合伙人
  • Samuel Han , Managing Director  & Global Partner of Boston Consulting Group
  • 冯昊 ， 镁信健康首席创新官
  • FENG Hao , Chief Innovation Officer of Meditrust Health
16:40 - 17:30
  • 主题讨论2
  • Panel Discussion 2
  • 立足湾区、面向世界
  • Based on Guangdong-Hong Kong-Macao Greater Bay Area to Embrace the World
    • Moderator
  • 康韦 ， RDPAC执行顾问
  • KANG Wei , Executive Advisor at RDPAC
    • Panelists
  • 陈诗涛 ， 香港特別行政区政府卫生署总药剂师
  • CHAN Sze Tao , Chief Pharmacist of Department of Health of Hong Kong Special Administrative Region Government
  • 邵蓉 ， 中国药促会医药政策专业委员会副主任委员、中国药科大学药品监管科学研究院执行院长
  • SHAO Rong , Vice-Chairman of Medicinal Policy Specialty Committee of PhIRDA, Executive Dean of Institute of Regulatory Science of China Pharmaceutical University
  • 郑小飞 ， 暨南大学附属第一医院院长
  • ZHENG Xiaofei , President of the First Affiliated Hospital of Jinan University
  • 胡元佳 ， 澳门大学药品监管科学研究中心主任
  • HU Yuanjia , Director of the Scientific Research Center for Drug Regulation at the University of Macau